8-K: U.S. Physical Therapy Reports Record Patient Volumes and Increased Dividend Despite Medicare Rate Headwinds

U.S. Physical Therapy reported record patient volumes for 2023 and increased its quarterly dividend, while also navigating a challenging reimbursement environment.

Summary

• U.S. Physical Therapy (USPH) announced its fourth quarter and full year 2023 results, showing a $4.1 million increase in adjusted EBITDA to $77.7 million for the full year.
• Operating results for the full year were $36.3 million, a $1.3 million increase from the previous year, though per-share operating results decreased to $2.56 due to an increase in shares outstanding from a secondary offering.
• Net income attributable to USPH shareholders was $28.2 million for the full year, down from $32.2 million in the prior year, impacted by a $17.5 million non-cash impairment charge in the fourth quarter.
• Fourth quarter adjusted EBITDA was $19.0 million, a $1.1 million increase year-over-year, and operating results were $8.9 million, a $1.3 million increase.
• Total net revenue for the fourth quarter increased by 9.6% to $154.8 million, with a net rate per patient visit of $103.68.
• The company achieved record-high average daily visits per clinic of 29.9 for the fourth quarter and 30.0 for the full year.
• Patient visits increased by 10.0% in the fourth quarter and 11.6% for the full year, reaching 5,005,426 visits.
• The company added 46 new clinics and closed 15 during the year, ending with 671 clinics.
• The quarterly dividend was increased from $0.43 to $0.44 per share.
• Management expects 2024 adjusted EBITDA to be between $80 million and $85 million, despite a Medicare rate reduction.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to record patient volumes and increased dividend, but tempered by decreased net income and earnings per share, as well as a non-cash impairment charge and Medicare rate reduction headwinds.

Positives

• The company experienced record physical therapy volume for each quarter of 2023 and for the full year.
• The industrial injury prevention services business showed acceleration in progress and opportunity.
• The company has a strong balance sheet due to a capital raise in 2023.
• The company is actively seeking acquisitions and partnerships.
• Net rate per patient visit has increased sequentially each quarter since the second quarter of 2023.
• The company's cash position significantly improved to $152.8 million as of December 31, 2023, compared to $31.6 million the previous year.

Negatives

• Net income attributable to USPH shareholders decreased to $28.2 million for the full year 2023, down from $32.2 million in the prior year.
• Earnings per share decreased to $1.28 for the full year 2023, compared to $2.25 in the previous year.
• The company incurred a $17.5 million non-cash impairment charge in the fourth quarter of 2023.
• The net rate per patient visit decreased slightly for the full year 2023 to $102.80 from $103.63 in the previous year.
• The company faces headwinds from a Medicare rate reduction of approximately 3.5% effective January 1, 2024.

Risks

• The company faces risks related to changes in Medicare rules and reimbursement rates.
• The company is exposed to potential retroactive reductions in revenue from Medicare and Medicaid.
• The company is subject to compliance with federal and state laws regarding patient information privacy.
• The company faces competitive, economic, and reimbursement challenges in its markets.
• The company's debt and financial obligations could adversely affect its financial condition.
• The company is exposed to risks related to hiring, training, and retaining qualified employees.
• The company is subject to risks related to cyber-attacks and security breaches.
• The company is exposed to risks related to the termination or non-renewal of contractual service arrangements.
• The company is exposed to risks related to the successful integration of acquired businesses.
• The company is exposed to risks related to the retirement or resignation of key partners.
• The company is exposed to risks related to general economic conditions, including inflationary and recessionary periods.

Future Outlook

Management expects the company's Adjusted EBITDA for 2024 to be in the range of $80 million to $85 million, despite a Medicare rate reduction. They anticipate offsetting the Medicare rate reduction through rate negotiations, volume increases, expense control, and contributions from acquisitions.

Management Comments

• Chris Reading, Chief Executive Officer, stated that the team finished the year strong with record physical therapy volume and that the company has a great balance sheet to attract more partner-owners.
• Carey Hendrickson, Chief Financial Officer, expressed confidence in the team's ability to produce EBITDA growth in 2024, despite headwinds from the Medicare rate reduction, through rate negotiations, volume growth, and cost efficiencies.

Industry Context

This announcement reflects a trend in the healthcare industry where providers are focusing on volume growth and cost management to offset reimbursement pressures. The company's focus on acquisitions and partnerships is also a common strategy for growth in the fragmented physical therapy market.

Comparison to Industry Standards

• USPH's patient visit growth of 11.6% for the full year 2023 is strong compared to industry averages, which typically see single-digit growth.
• The company's adjusted EBITDA margin of approximately 12.8% for the full year 2023 is within the range of other publicly traded physical therapy providers such as Select Medical (SEM) and ATI Physical Therapy (ATIP), although these companies have different business models and may not be directly comparable.
• The increase in the quarterly dividend to $0.44 per share demonstrates a commitment to shareholder returns, which is a positive signal compared to peers that may not offer dividends.
• The company's focus on acquisitions is consistent with the industry trend of consolidation, as smaller practices seek to join larger networks for better resources and negotiating power.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and potential for future growth.
• Employees may see opportunities for advancement as the company expands through acquisitions and new clinic openings.
• Customers will have access to more physical therapy clinics and services.
• Suppliers may see increased demand for their products and services.
• Creditors may see the company as a more stable borrower due to its improved cash position.

Next Steps

• The company plans to continue acquiring outpatient physical therapy practices.
• The company plans to develop outpatient physical therapy clinics as satellites in existing partnerships.
• The company plans to continue acquiring companies that provide or serve the company's industrial injury prevention services.
• The company will host a conference call on February 29, 2024, to discuss the financial results.

Key Dates

Keywords

physical therapy, outpatient clinics, industrial injury prevention, EBITDA, revenue, patient visits, acquisitions, dividend, Medicare, financial results